Aug. 21 at 5:41 PM
$SMCI 🚨 Trade on facts, not froth.
📊 Q4 FY26:
• Revenue:
$11.1B, +91% YoY
• Adj. EPS:
$1.70
• Gross margin: 17.6%, vs. 9.6% YoY
• Net income:
$1.18B, vs.
$195M
• FY27 revenue guide:
$65–72B
💰 VALUATION: SMCI sits around a low-teens forward P/E, a huge discount considering its AI growth.
$DELL/
$HPE generally command comparable/higher earnings multiples, while
$CRWV/
$NBIS receive massive growth valuations despite much weaker/negative profitability.
And now another major overhang is easing: the independent investigation found no evidence current senior management knew of the alleged diversion and no finding that SMCI directly sold controlled products to known restricted parties.
$65–72B revenue outlook + real profits + discounted P/E + fading regulatory narrative.
Give SMCI an 18–20× multiple and the rerating math gets VERY interesting. 🚀
